1. Home
  2. MAN vs MPLT Comparison

MAN vs MPLT Comparison

Compare MAN & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ManpowerGroup

MAN

ManpowerGroup

N/A

Current Price

$32.77

Market Cap

1.4B

ML Signal

N/A

MPLT

MapLight Therapeutics Inc.

N/A

Current Price

$28.74

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MAN
MPLT
Founded
1948
2018
Country
United States
United States
Employees
N/A
133
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
MAN
MPLT
Price
$32.77
$28.74
Analyst Decision
Hold
Strong Buy
Analyst Count
6
7
Target Price
$35.67
$32.67
AVG Volume (30 Days)
790.6K
266.0K
Earning Date
04-16-2026
05-28-2026
Dividend Yield
4.69%
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$17,957,100,000.00
N/A
Revenue This Year
$5.12
N/A
Revenue Next Year
$3.42
N/A
P/E Ratio
$646.00
N/A
Revenue Growth
0.58
N/A
52 Week Low
$25.15
$12.24
52 Week High
$47.34
$33.28

Technical Indicators

Market Signals
Indicator
MAN
MPLT
Relative Strength Index (RSI) 62.10 51.12
Support Level $28.29 $26.20
Resistance Level $40.27 $31.88
Average True Range (ATR) 1.51 2.15
MACD 0.42 -0.18
Stochastic Oscillator 91.91 62.68

Price Performance

Historical Comparison
MAN
MPLT

About MAN ManpowerGroup

ManpowerGroup Inc provides workforce solutions and services, including recruitment and assessment, upskilling, reskilling, training and development, career management, outsourcing, and workforce consulting. The company leverages its trusted brands, industry knowledge, and AI-enabled assessments and offers an extensive portfolio of training and leadership development solutions. Its reportable segments are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others, with Staffing and Interim generating the majority of revenue. It operates in the Americas, Southern Europe, Northern Europe, and APME. The company derives the maximum geographical revenue from the Southern European region.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: